ArticleFrontiers in oncology2026

Case Report: Remarkable response to savolitinib plus chemotherapy and bevacizumab in second-line treatment of MET amplified colon cancer with liver metastasis.

Ying Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.